$CGAC BREAKING NEWS! The company will incorporate the new Hemp Code line into the portfolio

Code Green Apparel Explores Development of Hemp-Based Textiles to Broaden Its Sustainable Apparel Product Line

By AccessWire,  April 25, 2017, 10:00:00 AM EDT

LAGUNA BEACH, CA / ACCESSWIRE / April 25, 2017 /Code Green Apparel Corp. (OTC-PINK:CGAC) announces the completion of the initial phases of the exploration of its newest product line, hemp-based textiles. After months of exploration, research and corporate customer dialogue, Code Green will begin development of a hemp-based product line immediately in an effort to broaden the assortment of sustainable fabrics it has to offer customers.

Code Green is strategically positioning itself to build on its already impressive portfolio of sustainable apparel products. The company will incorporate the new Hemp Code line into the portfolio, both horizontally and vertically. Management views the growth of the newest hemp-based lineup is twofold: 1) by tactically developing "product" in house while 2) strategically evaluating business relationships such as partnerships and Joint Ventures with other established companies in targeted, vertical markets.

Code Green has had many discussions with hemp suppliers, companies and experts and will combine each potential partner's respective expertise into a single venture. The current development stage will commence immediately and include fabric, design and product development in order to meet specific requests from customers.

"Code Green is excited about this new hemp-based opportunity, and we believe Hemp Code will provide continued growth into selected markets. The addition of the Hemp Code product line is a natural complement to our existing eco-friendly product lineup," stated George Powell, CEO of Code Green Apparel. "It is not sufficient to offer our customers only recycled products. We strive to create products from many sources of recycled and sustainable textile products. We will move quickly and efficiently, yet responsibly, to make our vision a reality. While we expect the hemp-based product line to provide new customers, the addition Hemp Code will not take any effort or capital away from our existing products nor order fulfillment. We will keep you informed of developments and opportunities as they develop."

About Code Green Apparel

Code Green Apparel Corp is dedicated to becoming an industry leader in Sustainable Textiles through its Process of creating Eco-friendly clothing providing corporations with Corporate Logo Wear, Uniforms and other Eco-Friendly Sustainable Textile products. Management boasts over 75 years of textile experience in the apparel industry and intends to be disruptive in the market. Code Green intends to launch a wide range of products that meet the needs of today's consumers using upcycled textiles.

www.codegreenapparel.com

Legal Disclaimer

This press release may contain forward-looking statements including words such as "may," "can," "could," "should," "predict," "aim," "potential," "continue," "opportunity," "intend," "goal," "estimate," "expect," "expectations," "project," "projections," "plans," "anticipates," "believe," "think," "confident," "scheduled," or similar expressions, as well as information about management's view of Code Green Apparel's future expectations, plans and prospects. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Code Green Apparel, its divisions and concepts to be materially different than those expressed or implied in such statements. These risk factors and others are included from time to time in documents Code Green Apparel files with the Securities and Exchange Commission, including, but not limited to, its Form 10-Ks, Form 10-Qs and Form 8-Ks. Other unknown or unpredictable factors also could have material adverse effects on Code Green Apparel's future results. Code Green Apparel cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Such forward-looking statements should not be relied upon as indicative of current value or as a guarantee of future results, herein, and shall not be relied upon as a promise or representation.

In this release, we may rely on and refer to information regarding our industry and the market for our products in general from market research reports, analyst reports and other publicly available information. Although we believe that this information is reliable, we cannot guarantee the accuracy and completeness of this information, and we have not independently verified any of it. Some data is also based on our good faith estimates.

SOURCE: Code Green Apparel

This article appears in: News Headlines

Referenced Stocks: CGAC

Read more: http://www.nasdaq.com/press-release/code-green-apparel-explores-development-of-hempbased-textiles-to-broaden-its-sustainable-apparel-20170425-01053#ixzz4fH2smTIP

ImmunoGen, Inc. (NASDAQ:IMGN) Presents Phase 1 Biopsy Expansion Cohort Data At The Society Of Gynecologic Oncology Annual Meeting

ImmunoGen, Inc. (NASDAQ:IMGN) has announced that data from Phase 1 of mirvetuximab soravtansine (IMGN853) has shown that the archival tumor tissue is able to identify patients suffering from folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer. The company will be presenting the data at the Society of Gynecologic Oncology (SGO) Annual Meeting which is scheduled for March 12-15 in National Harbor, MD.

Comparing the levels of FRα in pre-treatment biopsies against archival samples confirms the use of archival tumor tissue in selecting the patients. Out of the 21 pre-treatment samples evaluated, 15 were eligible for the biopsy expansion cohort. This translates to a concordance level of 71% with archival tumor tissues. 22% of the patients admitted failed to meet the pre-treatment biopsies required to evaluate the FRα immunohistochemistry because they had less tumor cells in the specimen. In addition, biopsies taken before and after two mirvetuximab soravtansine doses revealed similar levels of FRα expression.

The data also support using a pre-treatment biopsy for selection of patients in the event that archival tumor tissue cannot be used for evaluation.  According to ImmunoGen Vice President and Chief Medical Officer Anna Berkenblit, the results that will be presented at SGO are in line with the company’s strategy to select patients for admission in the Phase 3 FORWARD I trial. The data also show that mirvetuximab soravtansine has higher levels of tolerance.

A total of 27 heavily pretreated patients among them patients with as much as 11 previous therapies were admitted for the biopsy expansion cohort basing on levels of FRα expression in the archival tumor tissue. Patients were subjected to pre-treatment biopsy before being administered with mirvetuximab soravtansine in addition to another post-treatment biopsy fare receiving two mirvetuximab soravtansine doses.

The cohort’s safety profile concurred with what was reported in the patients treated with mirvetuximab soravtansine during the Phase 1 trial which exhibited a lot of Grade 1 and 2 adverse events. Going by the FRα expression in both pre-treatment and archival biopsies, the data also showed an increase in anti-tumor activity with higher levels of FRα expression.

In the six month-period, operating expenses stood at $89.0 million which is below the $89.7 million reported for the six months from the previous financial year.  The current period’s operating expenses is inclusive of the $66.6 million for research and development compared to the $73.3 million reported in the previous period. The change is as a result of a reduction in third party costs from activities carried out in the previous period to support mirvetuximab soravtansine development, reduction in costs related to production of clinical materials on behalf of partners as well as a decrease in antibody and cytotoxic costs as a result of timing of supply requirements.

On the financial front, the company reported revenue from the six-month period ended ended December 31 2016 amounting to $21.5 million. This is in comparison to the $32.9 million reported the same period the previous year. Fees from license and milestone during the period amounted to $5 million compared to the $8.6 million that the company received from Takeda as well as the $8 million that was received from partner milestone payments before the period.  The current period, the company’s revenue include $12.9 million worth of non-cash revenues as compared to $12.0 million worth of non-cash revenues and $0.2 million in cash royalty revenues in the previous period. The current period revenue also includes $2.8 million worth of research and development as well as the $0.7 million for purchase of clinical material. This is in comparison to the $1.6 million and $2.3 million respectively that were reported in the previous period.

What AMD's (NASDAQ:AMD) New Ryzen 5 Desktop Processor Means In The Semiconductor Battle With Intel (NASDAQ:INTC)

What AMD's (NASDAQ:AMD) New Ryzen 5 Desktop Processor Means In The Semiconductor Battle With Intel (NASDAQ:INTC)

3:56:00 PM

When it comes to the best performance for the price in the semiconductor space, two major brands have been toe-to-toe since the late 80's; This article concerns itself with the mid-level computing performance which is not the highest or lowest, but the mainstream retail buyers most lucrative bang for the buck. 

AMD (NASDAQ:AMD) and Intel (NASDAQ:INTC). The new generation of consumer is always seeking the best price-to-performance ratio when shopping for computer hardware, and now, with the arrival of the market's highest performing 6-core processors, investors are on the sidelines wondering what AMD's new Ryzen desktop processor means in the semiconductor battle.

AMD's (NASDAQ:AMD) Ryzen processors have proven themselves to be powerful and, simply put, a good bang for the buck when compared to Intel's (NASDAQ:INTC) Core-i5 processor. Pit both Company's $250 offerings against each other and the Ryzen comes out on top when it comes to multi-threaded applications. Let's take a look at the technical comparison below.

But wait! Don't label the AMD Ryzen 5 1600X as the winner just yet. When it comes to gaming, the Intel Core i-5 7600k comes out on top. But just barely. This is subject to change as games have yet to be optimized for Ryzen's multi-core architecture.

Is AMD's Ryzen processor enough to blow away the competition, upend brand loyalty, and spontaneously push the stock above its 12-month rally of 350%? No. Not quite.

AMD (NASDAQ:AMD) has had a 12-month rally of over 350%

When it comes to Intel (NASDAQ:INTC), the Company is the leader in the cloud-computing and server space, commanding over 90% of the data center market share.  Intel announced in March of this year that it is in the process of buying Mobileye (NYSE:MBLY), effectively positioning itself in the driverless car market.

Intel (NASDAQ:INTC)

When it comes to AMD (NASDAQ:AMD), the Company holds around 30% of the desktop GPU (Graphics Processing Unit) market share. This number is up from last year when savvy consumers leaned in the direction of AMD's Radeon GPUs. AMD is well established in console gaming market with its custom chips powering Sony's (NYSE:SNE) PlayStation 4 and the Microsoft's (NASDAQ:MSFT) Xbox One.

Microsoft (NASDAQ:MSFT) chart

Let's not forget, however, that Intel has a patent licensing deal with one of AMD's major contenders, Nvidia (NASDAQ:NVDA). And as things stand at current, Nvidia's new Pascal architecture is no match for AMD's Polaris platform.

Nvidia (NASDAQ:NVDA) chart

The choice for investors is a complicated one and it all boils down to perspective. In the long term, both companies are in good hands fundamentally as the semiconductor market is set to be rife with opportunities as "The Internet of Things" phenomenon progresses. Will AMD's Ryzen Processor be enough to continue it's rally? That remains to be seen. The battle of the semiconductors rages on.

North Atlantic Drilling Ltd. (NYSE:NADL) Soars Over +200%

North Atlantic Drilling Ltd. (NYSE:NADL) Soars Over +200% On News Of 10-Year Contract With ConocoPhillips Skandinavia AS

10:49:00 AM

Shares of North Atlantic Drilling Ltd. (NYSE:NADL) are reaching as high as $2.41, up 228% mid-day today, Tuesday April 11th, 2017, following the announcement of a 10-year contract with CoconoPhillips Skandinavia AS.  The new contract awarded is estimated to exceed revenues of $1.4 billion. This figure is excluding performance bonuses.

The press release explains, as part of the agreement, the Company has agreed to a day rate adjustment on the existing West Linus contract effective from April 2017, resulting in a $58 million reduction in contract backlog, It's important to note, however, that the other leases are reported as seeing increases in possible revenues totaling the aforementioned $1.4 billion dollars.

The new West Elara contract which is expected to commence in October 2017. As reported in the press release, this includes a period of fixed day rates until March 2020 and contributes approximately $160 million of contract backlog, which refers to unfinished work or to customer orders that have been received but are either incomplete or in the process of completion.

A market indexed rate which represents an entire stock market and thus tracks the market's changes over time, is applicable thereafter until October 2027.  The Company believes this generates an estimated $530 million of contract backlog (revenues expected after orders are filled and shipped).

The contract on West Linus has been extended from May 2019 until the end of 2028 at a market indexed dayrate, which the Company believes will contribute another estimated $706 million of contract backlog.

These backlogs estimate indications via the overall market indexed rate period for each Oil rig and is based on the third party dayrate estimates presented in the Seadrill Limited release dated January 31, 2017, which is highly reputable and includes an agreed percentage discount. Of course, all estimates are subject to changes based on market conditions.

About North Atlantic Drilling Ltd. Ltd. (NYSE:NADL)

North Atlantic Drilling is a leading offshore harsh environment drilling company, aiming to be our customers' most important partner in making oil and gas available in a safe and cost-effective manner. The company has a fleet of eight harsh environment units in operation and one new build under construction. North Atlantic Drilling has some 600 skilled and highly competent employees.

North Atlantic Drilling is a 70.4 percent owned subsidiary of Seadrill Limited, and has its shares listed on the NYSE.

$INND News Innerscope Advertising Agency Inc.

• 
  
  
  Innerscope Advertising Agency Inc. (OTCTRADING SYMBOL: INND) was initially formed to monetize the founder’s vast experience in generating traffic through hearing aid dispensing practices. The founders of INND have decades of hands on experience and have built some of the largest hearing aid retail operations in the US. The company decided to go public to facilitate its aggressive expansion plan in an industry expected to double over the next 10 years. Revenue streams of the company has expanded to include:
  • Advertising and marketing service based on proven, proprietary models
  • Clinic design services that are unique to the industry, including Clinic set-up, customer relations management and sales techniques
  • Expansion of their core ‘cooperative buying group’ enabling independent hearing aid practitioners to leverage their collective purchasing power of hearing devices by aggregating their purchases
  • Become a leader in the auditory rehab market utilizing interactive web and mobile based self-assessment and training modules.
  Matthew Moore, CEO of INND, states, “The hearing aid industry is undergoing the greatest expansion in its history. We have been first hand witnesses to virtually every innovation over the last three decades and feel we are uniquely qualified to identify and capitalize on current and future trends. Our goal is to build a nimble organization of forward leaning opportunities and in the process build great enterprise value for all of our stakeholders.”

 Overview Profile Financials Income Statement Balance Sheet Cash Flow Research & Ratings Historical Prices Options Advanced Charting ALL SECTIONS

                                     Innerscope Advertising Agency Inc.

•   

 For more information, please visit www.innerscopeadagency.com

Lamperd Less Lethal, Inc. (OTCMKTS:LLLI) has developed and manufactured less-lethal technology and ammunition for over 40 years.

Lamperd Less Lethal has been assigned a NATO Commercial and Government Entity (NCAGE) Code, which enables it to sell military supplies to any NATO member country, and a Federal Business Firearms License, which allows for the manufacture, repair, storage, import, export and sale of virtually any manner of firearms and ammunition. 

Lamperd Less Lethal is one of only a very few manufacturers of less-lethal munitions in the world to receive these approvals.

Lamperd Less Lethal (OTCMKTS:LLLI) Receives Largest Purchase Order In Two Years

Announced in early February, 2017, Lamperd Less Lethal, Inc., (OTCMKTS:LLLI), a developer, manufacturer and international sales company for less lethal weapons and ammunition, announced it has received a significant new purchase order from one of its distributors. The order is 140% larger than any order Lamperd has received in the past two years. The purchase order has already been funded and product shipments were mentioned to commence shortly.

An order of this size comes as no surprise, considering all of the civil unrest going on in the United States, generating such demand for less-lethal equipment. The Dakota Access Pipeline struggle and the protests following Trump's inauguration are causing quite a ruckus. Riots are on the rise and law enforcement agencies are using less-lethal methods to deal with them. Lamperd Less Lethal, Inc.(OTCMKTS:LLLI) can provide the equipment. Lamperd is preparing for a significant U.S. increase order flow in 2017.

Lamperd Less Lethal, Inc. (OTCMKTS:LLLI) has developed and manufactured less-lethal technology and ammunition for over 40 years. Lamperd Less Lethal has been assigned a NATO Commercial and Government Entity (NCAGE) Code, which enables it to sell military supplies to any NATO member country, and a Federal Business Firearms License, which allows for the manufacture, repair, storage, import, export and sale of virtually any manner of firearms and ammunition. Lamperd Less Lethal is one of only a very few manufacturers of less-lethal munitions in the world to receive these approvals.

Lamperd Less Lethal, Inc. (OTCMKTS: LLLI) made mention that it is also introducing new products. The reloadable Lamperd Smoke Grenade offers a tracer flare and different color smoke options. Lamperd is also introducing the new aerial burst pepper spray grenade. This one of a kind munition weighs in at only 1.5 oz. and effectively controls people within an area of 200 sq. ft.

Lamperd is gaining a lot of interest in different NATO countries and are preparing new sales quotes for numerous products including ammunition orders.